The cell cycle-regulated transcription factor E2F is a family of heterodimers composed of E2F and DP protein subunits. While DP proteins stabilize DNA binding of E2F proteins, and in¯uence the entry of E2F-4 and E2F-5 into the nucleus, the role of DP proteins in E2F-dependent gene expression is not well understood. Using immunolocalization, immunoprecipitation, and cell fractionation experiments, here we show association with E2F subunits governs intracellular tracking and ubiquitination of DP-1. In transient transfection experiments, DP-1 polypeptides that stably bound E2F-1 entered the nucleus. DP-1 proteins that failed to associate with E2F subunits accumulated in the cell cytoplasm as polyubiquitinated DP-1. A Chinese hamster cell line that conditionally expresses HA-DP-1 was used to examine the eect of DP-1 on cell cycle progression. In serum response experiments, moderate increases in HA-DP-1 led to a threefold increase in E2F DNA binding activity in vitro, a corresponding increase in dhfr gene expression during transition of G1, and higher rates of S phase entry. However,¯ow cytometry showed cells expressing very high levels of HA-DP-1 failed to enter the S phase. Inhibition of cell cycle progression by high levels of HA-DP-1 was associated with the accumulation of other ubiquitinated cellular proteins, including c-jun and the cyclin-dependent kinase inhibitor p21, indicating that degradation of ubiquitinated proteins is required for progression from G 0 to S phase even in the presence of activated E2F. Under similar conditions, expression of E2F-1 reduced the levels of ubiquitinated cellular proteins and accelerated cell cycle progression. Our studies indicate association with E2F subunits prevents ubiquitin-dependent degradation of DP-1 in the cytoplasm by promoting nuclear entry of E2F/DP heterodimers.
Introduction
Traversal of G1 and entry into the S phase requires the periodic expression of genes involved in cell cycle progression and DNA replication. One factor involved in controlling progression through the G1 phase is E2F, a family of heterodimeric transcription factors that associate with several important cell cycle regulators, including the retinoblastoma family of tumor suppressor proteins (pRB, p107, and p130) and cyclin-dependent kinases (CDKs) (reviewed by Farnham et al., 1993; Beijersbergen and Bernards, 1996; Sanchez and Dynlacht, 1996) . Molecular cloning and biochemical analysis of E2F has shown that the transcriptionally active forms of E2F are heterodimers, with one subunit encoded by the E2F-like gene family and the second encoded by the DP-like gene family Girling et al., 1993; Helin et al., 1993; Wu et al., 1995) .
In mammals, cDNA clones that encode ®ve E2F-like polypeptides and three DP-like polypeptides have been described (reviewed by Slansky and Farnham, 1996) . E2F-1, E2F-2 and E2F-3 are structurally related, whereas E2F-4 and E2F-5 represent a distinct subclass of E2F polypeptides (Sardet et al., 1995; Slansky and Farnham, 1996) . For example, E2F-1, E2F-2 and E2F-3 interact with pRB, whereas E2F-4 and E2F-5 associate preferentially with p107 and p130 (reviewed by Weinberg, 1995; Beijersbergen and Bernards, 1996) . Deregulated expression of the E2F proteins that bind pRB (E2F-1, E2F-2 and E2F-3) has dramatic eects on cell cycle progression. Expression of E2F-1 induces cells to enter the S phase in the absence of growth factors, and can lead to both cellular transformation and apoptosis (reviewed by Adams and Kaelin, 1996) . Recently, expression of E2F-1 has been shown to obviate G1-arrest induced by inhibitors of G1 CDKs (DeGregori et al., 1995; Lukas et al., 1996) .
Although DP-1 and DP-2 share similarities with E2F proteins in their DNA binding and dimerization domains, neither protein activates gene expression or independently directs the association of E2F with pRB family members or CDKs. Rather, DP-1 and DP-2 associate with E2Fs 1 ± 5 and potentiate transcription through consensus E2F DNA binding sites (Bandara et al., , 1994 Girling et al., 1993; Helin et al., 1993; Huber et al., 1993; Wu et al., 1995) .
To understand the role of DP-1 in E2F-dependent gene expression, we have examined the expression of DP-1 in transient transfection experiments and in stable cell lines. Here we show that association with E2F subunits in¯uences intracellular tracking and polyubiquitination of DP-1. DP-1 that associates stably with E2F subunits enters the nucleus, while DP-1 that fails to associate with an E2F subunit is ubiquitinated and targeted for degradation in the cytoplasm. Thus, ubiquitin-dependent proteolysis may contribute to the regulation of E2F activity by maintaining the balance between E2F and DP protein subunits. Moreover, in contrast to E2F-1, which accelerates cell cycle progression, ectopic expression of HA-DP-1 at high levels led to cell cycle arrest by inducing the accumulation of other ubiquitinated proteins, including the CDK inhibitor (CKI) p21.
Results

Ectopic DP-1 is polyubiquitinated
To assess the individual eects of E2F and DP proteins on gene expression and cell cycle progression, we have expressed various forms of these factors in several mammalian cell lines. Western blot analysis of extracts from human or hamster cells transfected with pCMV-DP-1 with monoclonal antibody WTH10 consistently showed high molecular weight forms of immunoreactive material. Several observations suggested that the higher molecular weight material was polyubiquitinated DP-1: the immunoreactive material was dependent upon expression of DP-1, was stable to boiling in SDS and b-mercaptoethanol, and reacted speci®cally with several polyclonal and monoclonal antibodies against DP-1 (data not shown).
To determine if DP-1 is a substrate for ubiquitination, DP-1 was immunoprecipitated from CHOC 400 cells that were cotransfected with pCMV-DP-1 and pCMV-HA-ubiquitin (HA-ubq), a plasmid that expresses ubiquitin multimers, each of which is tagged with the in¯uenza virus HA epitope. After cleavage of the HA-ubiquitin multimers by ubiquitin hydrolases, HA-tagged ubiquitin serves as an ecient substrate for ubiquitin conjugating enzymes in cells, thereby facilitating the detection of proteins modi®ed by ubiquitination with anti-HA monoclonal antibody 12CA5 (Treier et al., 1994) . Twenty-four hours after transfection, cells were lysed under denaturing conditions (i.e. in PBS containing 2% SDS), the total cell Figure 1 Polyubiquitination of DP-1 (a) DP-1 is ubiquitinated in CHOC 400 cells. CHOC 400 cells were transfected with pCMV-DP-1 (lanes 1 ± 6) and either no additional expression plasmid (lanes 1 and 2), pCMV-HA-ubiquitin (lanes 3 and 4), or pCMV-his 6 -ubiquitin (lanes 5 and 6). After 24 h, immunoprecipitations were performed with either monoclonal antibody KH20 or WTH10. A Western blot of the immunoprecipitates was probed with monoclonal antibody 12CA5 against the HA epitope tag. The bracket indicates DP-1 covalently modi®ed by HA-ubiquitin; the arrow denotes signal from the heavy chain of monoclonal antibody KH20. (b) A Western blot identical to that in (a) was probed for DP-1 with monoclonal antibody WTH10: the bands at 60 kd represent non-speci®c signal from the heavy chains of monoclonal antibodies KH20 and WTH10. (c) DP-1 is polyubiquitinated in human cells. The indicated cell lines were transfected with pCMV-DP-1 and pCMV-HA-ubiquitin, extracts were prepared, and DP-1 was immunoprecipitated with WTH10 as in a. The bracket indicates DP-1 covalently modi®ed by HA-ubiquitin lysate was diluted, and DP-1 was immunoprecipitated with monoclonal antibody WTH10. Western blots of the immunoprecipitates then were probed with monoclonal antibody 12CA5. WTH10 immunoprecipitated a series of 12CA5-reactive proteins from cells transfected with pCMV-DP-1 and pCMV-HA-ubq that migrated on denaturing polyacrylamide gels with apparent molecular weights between 60 and 4200 kd ( Figure  1a , lane 4). Material that reacted with 12CA5 was not observed in WTH10 immunoprecipitations from cells transfected with pCMV-DP-1 only (lane 2), or in cells transfected with pCMV-DP-1 and pCMV-his 6 -ubq (lane 6).
Immunoprecipitations performed with monoclonal antibody KH20 to E2F-1 as a control antibody did not contain high molecular weight proteins that reacted with 12CA5 in cells transfected with pCMV-DP-1 only ( Figure 1a, lane 1) , or in cells transfected with pCMV-DP-1 and either pCMV-HA-ubq (lane 3) or pCMVhis 6 -ubq (lane 5). In replicate blots, WTH10 recognized DP-1 only in immunoprecipitates from cells transfected with pCMV-DP-1 (Figure 1b , lanes 2, 4 and 6). Similar immunoprecipitation experiments showed DP-1 also is polyubiquitinated when expressed in the human cell lines C33A, Saos-2 and U2OS cells ( Figure 1c , lanes 2, 4 and 6).
Association with E2F-1 protects DP-1 from polyubiquitination
Indirect immuno¯uorescence microscopy showed DP-1 accumulates in the cytoplasm when expressed in the absence of an E2F partner (Magae et al., 1996; Lindeman et al., 1997) . We therefore performed cell fractionation and immunoprecipitation experiments to determine the eect of association with E2F-1 on polyubiquitination of DP-1. Cells were cotransfected with pCMV-DP-1, pCMV-HA-ubq, and one of several plasmids that express truncated forms of E2F-1. Preliminary experiments showed ubiquitinated DP-1 could not be extracted from transfected cells in immunoprecipitation buers containing low salt concentrations and 0.5% Triton X-100 (data not shown). Therefore, whole cell extracts (WCEs) were prepared by a freeze-thaw procedure in buer containing 0.5 M KCl (Helin et al., 1993) , which is a suciently high salt concentration to extract the majority of E2F DNA binding complexes from the CHO cell nucleus (Wells et al., 1996) . Immunoprecipitation experiments were conducted with both WCEs, which contain cellular proteins that remain soluble after centrifugation of the WCE at high speed, and residual cell pellets, which were solubilized in SDS and diluted in PBS prior to immunoprecipitation.
To examine the forms of DP-1 that associated with E2F-1 in cells, immunoprecipitations were performed using WCEs, but with monoclonal antibody KH-20 against E2F-1, and then probed with antibodies against DP-1. Because residual cell pellets were resuspended in SDS, coprecipitation of E2F/DP protein complexes from this cell fraction was not feasible.
When DP-1 was coexpressed with HA-ubq and a form of E2F-1 that is unable to stably associate with DP-1 (i.e. E2F-1 1-191), polyubiquintated DP-1 was recovered from the insoluble cell pellet (Figure 2b , lanes 2 and 4). Under these conditions, DP-1 was not recovered from the soluble WCE by immunoprecipitation with KH-20 against E2F-1 (lane 8). Coexpression of E2F-1 1-374, which forms stable complexes with DP-1 that localize to the nucleus (Magae et al., 1996) , resulted in recovery of DP-1 from both the insoluble cell pellet by antibodies against DP-1 (Figure 2b , lane 6), and from the soluble WCE by antibodies against E2F-1 (Figure 2b , lane 12). DP-1 recovered from either cell fraction was not modi®ed by HA-ubq. Coexpression with E2F-1 1-284 reduced, but did not abolish, polyubiquitination of DP-1 (lanes 4 and 10).
While E2F-1 1-284 contains the heptad repeat and marked box implicated in dimerization with DP-1 (Helin et al., 1993; Wu et al., 1995; Vidal et al., 1996) , immuno¯uoresence microscopy showed that both E2F-1 1-284 and DP-1 are distributed within the cytoplasm and nucleus when the two proteins are coexpressed (Figure 3 ). Previous work indicates that heterodimers of DP-1 and E2F-1 1-277 are unstable , suggesting E2F-1 1-284 does not induce complete localization of DP-1 within the nucleus due to instability of E2F-1 1-284/DP-1 heterodimers. Under identical conditions, both DP-1 Figure 2 Association with E2F-1 prevents ubiquitination of DP-1. (a) The domain structure of E2F-1. The regions of E2F-1 encompassed in truncated E2F-1 polypeptides that were coexpressed with DP-1 in b are indicated. (b) Whole cell extracts were prepared from cells transfected with pCMV-DP-1, pCVM-HA-ubiquitin, and the indicated E2F-1 expression plasmid. DP-1 in the insoluble cell pellet and E2F-1 complexes in the soluble WCE were immunoprecipitated using monoclonal antibodies WTH10 and KH-20, respectively. Western blotting was performed with mouse monoclonal antibody 12CA5 to detect HA-tagged ubiquitin (upper panel), or with rabbit polyclonal antibody K-20 to detect DP-1 (lower panel). Molecular weight markers are indicated on the right; the bracket denotes polyubiquitinated DP-1 and E2F-1 1-374 colocalize in the nucleus (Figure 3 ). DP-1 that was coexpressed with E2F-1 1-374 persisted in the nucleus after a 12 h incubation in cycloheximide, an inhibitor of protein synthesis, whereas DP-1 coexpressed with E2F-1 1-191 or with E2F-1 1-284 was undetectable in the nucleus or cytoplasm after treatment with cycloheximide under the same conditions ( Figure 3 , and data not shown). In the absence of cycloheximide, the immunostaining patterns for DP and E2F polypeptides were identical after 44 or 56 h of culture.
Together these data con®rm previous work showing both the heptad repeat (residues 206 ± 220) and the marked box (residues 235 ± 276) of E2F-1 are required for stable association with DP-1 (Helin et al., 1993; Vidal et al., 1996; Wu et al., 1995) , and that this association is required E2F DNA binding activity (Helin et al., 1993; Wu et al., 1995) and for nuclear localization of DP-1 (Magae et al., 1996; Lindeman et al., 1997) . Moreover, these results indicate the vast majority of polyubiquitinated DP-1 is located in the cytoplasm, and that association with E2F-1 prevents DP-1 from polyubiquitination, most likely by promoting nuclear entry of E2F/DP heterodimers into the cell nucleus. The eects of various E2F-1 polypeptides on the intracellular distribution and polyubiquitination of DP-1 are not related to the ability of these proteins or complexes to in¯uence gene expression directly, for none of the forms of E2F-1 used in these experiments contains a transactivation domain or is able to bind pRb, p130, or p107, and DP-1 alone is incapable of activating transcription.
CHOC 400 cell lines that conditionally express HA-E2F-1 and HA-DP-1
We were unable to recover stable cell lines that continuously expressed wild-type DP-1 or E2F-1 from pCMV expression plasmids (data not shown). Therefore, to compare the eect of DP-1 to that of E2F-1 on gene expression and cell cycle progression, cell lines that conditionally express epitope-tagged versions of these proteins from tetracycline-responsive promoters were generated. CHOC 400, a methotrexate-resistant strain of Chinese hamster ovary cells that contains ampli®ed copies of the dhfr gene (Milbrandt et al., 1981) was used as the progenitor cell line in these studies in order to provide a large number of endogenous reporter genes for E2F activity. Cell clones expressing HA-E2F-1 or HA-DP-1 under the control of tetracycline were identi®ed by Western blotting, and two representative clones that demonstrated conditional expression of full length HA-E2F-1 and HA-DP-1 mRNA and protein were selected for study. The properties of CHOC 400 cells that conditionally express HA-E2F-1 will be discussed elsewhere.
D1-38 cells express HA-DP-1 in a manner inversely proportional to the concentration of tetracycline in the culture medium ( Figure 4a ). Upon removal of tetracycline from the culture, increased levels of HA-DP-1 protein appeared within 4 h, and elevated expression was maintained for at least 48 h ( Figure  4b ). The level of expression of HA-DP-1 was similar in culture medium containing either 0.1 or 5% fetal Figure 3 Immunolocalization of DP-1 and E2F polypeptides. Cells transfected with pCMV-DP-1 and the indicated E2F-1 pCMV expression constructs were cultured for 44 h in the absence of cycloheximide, and were then either processed for immunostaining, or cultured for an additional 12 h in the presence of 10 mg/ml cycloheximide as indicated. Cells were stained for DP-1 with polyclonal antibody K-12 (green signal), for E2F-1 polypeptides with monoclonal antibody KH-20 (red signal), and nuclear DNA with DAPI (blue signal). No speci®c¯uorescence signal was detected for either DP-1 or E2F-1 polypeptides in cells cotransfected with pCMV-DP-1 and either pCMV-E2F-1 1-191 or pCMV-E2F-1 1-284 after incubation in cycloheximide (not shown) bovine serum (FBS), although ubiquitination of DP-1 appeared earlier and at higher levels in 5% FBS (compare lanes 2 ± 10 to lanes 12 ± 19, Figure 4c ). Note that HA-DP-1 is polyubiquitinated in D1-38 cells when expressed at high levels under any culture condition ( Figure 4a , b and c, brackets).
HA-DP-1 and E2F DNA binding activity
To ascertain if HA-DP-1 was functional in CHOC 400 cells, we examined its ability to associate with endogenous E2F subunits by gel mobility and antibody supershift experiments. When unsynchronized D1-38 cells were induced to express HA-DP-1, little change in E2F DNA binding activity was observed (compare lanes 2 ± 4 to lanes 5 ± 7, Figure 5a ). In serum response experiments, however, expression of HA-DP-1 led to a 3 ± 5-fold increase in E2F DNA binding activity by 12 h after addition of medium with 5% FBS (compare lanes 1 and 2, Figure 5b ). Addition of antibody WTH10 supershifted most of the E2F DNA binding activity in extracts of D1-38 cells grown either in the presence or absence of tetracycline (compare lanes 3 and 4, Figure 5b ), indicating DP-1 is the primary E2F partner in D1-38 cells whether or not HA-DP-1 is expressed. In contrast, addition of monoclonal antibody 12CA5 against the HA epitope supershifted E2F DNA binding activity only when HA-DP-1 was expressed (compare lanes 5 and 6, Figure 5b ). These results showed HA-DP-1 is able to form heterodimeric complexes with endogenous hamster E2F subunits, and that these complexes are able to bind the E2F sites of the hamster dhfr promoter in vitro.
Other supershift experiments showed that the Figure 4 Conditional expression of HA-DP-1 in D1-38 cells. Western blotting with monoconal antibody WTH10 to DP-1 was used to examine expression of HA-DP-1 in D1-38 cells after 24 h of incubation in the indicated concentration of tetracycline (a), after incubation in medium lacking tetracycline for the indicated period of time (b), or in serum starved cells after the addition of medium without tetracycline and either 0.1 or 5% fetal bovine serum (FBS) as a function of time (c). The brackets indicate polyubiquitined HA-DP-1 primary E2F partners of the free HA-DP-1/E2F complexes (complexes D and E, Figure 5b ) were E2F-44E2F-14E2F-2 (data not shown).
Expression of HA-DP-1 and dhfr gene expression
Given the increase in E2F DNA binding activity when HA-DP-1 was expressed during serum response experiments, we then examined the eect of expression of HA-DP-1 on dhfr gene expression. Growthregulated expression of dhfr is mediated in part by two overlapping and inverted E2F sites in the dhfr promoter (Azizkhan et al., 1993; Schilling and Farnham, 1994) . Expression of dhfr is repressed in serum-starved CHOC 400 cells: upon serum-stimulation, dhfr mRNA increases during the G1 to S phase transition, reaching maximal levels at 16 ± 18 h after addition of medium with serum, a time that represents the G1/S boundary of the cell cycle Wells et al., 1997) . D1-38 cells were collected in early G1 by incubating cells in medium containing 0.1% FBS and tetracycline for 48 h, and then were stimulated to traverse G1 and enter the S phase by addition of medium containing 5% FBS, with and without tetracycline. Total RNA was prepared and analysed for dhfr mRNA levels by Northern blotting. Flow cytometry was used to assess progression through G1 and entry into the S phase. Northern blotting showed HA-DP-1 mRNA was expressed at high levels by 8 h after the addition of medium with 5% FBS and no tetracycline (Figure 6a) . Expression of HA-DP-1 in D1-38 cells caused as much as a ®vefold increase in dhfr mRNA levels as compared to the control culture incubated in tetracycline ( Figure   Figure 5 HA-DP-1 participates in the formation of E2F DNA binding complexes. (a) Log phase CHOC 400 cells and D1-38 cells were incubated in the indicated concentration of tetracycline for 20 h, WCEs were prepared, and gel mobility shift assays were performed with equal amounts of protein using the overlapping E2F sites from the dhfr promoter as probe. E2F DNA binding complexes A ± E are indicated: antibody supershift experiments show that complex A is p107/E2F-4/DP-1, complex B is p130/ E2F-4/DP-1, complex C is pRB/E2F-1/DP-1, complex D is E2F-4/DP-1, and complex E is composed of three species: E2F-1, E2F-2, or E2F-3 with DP-1. See Wells et al., (1997) for details. (b) Expression of HA-DP-1 increases E2F DNA binding activity during serum stimulation. D1-38 cells were arrested in G1 by serum starvation, and were then induced to traverse G1 by addition of medium with 5% FBS with or without tetracycline as indicated. WCEs were examined for speci®c E2F DNA binding activity by gel mobility shift assays with or without the indicated monoclonal antibodies. Complexes supershifted by the addition of antibody are denoted by an arrow Figure 6 Expression of HA-DP-1 potentiates expression of dhfr mRNA during the G1 to S phase transition. D1-38 cells were arrested in early G1 by incubation in medium containing 0.1% FBS and tetracycline for 48 h. Medium containing 5% FBS, with and without tetracycline (TET), was then added (denoted as time 0). After the indicated period of time, replicate cultures were harvested and analysed for HA-DP-1 (a) and dhfr (b) mRNA levels by Northern blotting. (c) Hybridization signals from the Northern blot in panel b were quanti®ed and plotted as a function of time after the addition of medium with serum, with and without tetracycline as indicated 6, b,c). In addition, expression of HA-DP-1 induced maximal levels of dhfr mRNA by 16 h, approximately 4 h earlier than in D1-38 cells incubated with tetracycline and 5% FBS (Figure 6c ). Thus, in serum response experiments, expression of HA-DP-1 increased both the level of free E2F DNA binding complexes and the expression of dhfr mRNA about threefold, as well as altered the time at which maximal levels of dhfr mRNA were attained. With the gel mobility shift experiments presented in Figure 4b , these results indicate HA-DP-1 is fully functional in D1-38 cells. However,¯ow cytometry indicated that D1-38 cells that expressed high levels of HA-DP-1 under these conditions did not enter the S phase.
High levels of HA-DP-1 inhibit S phase entry
To examine the eect of HA-DP-1 on cell cycle progression in more detail, a serum response experiment was performed with D1-38 cells in varying concentrations of tetracycline. To arrest cells in early G1, D1-38 cultures were incubated in medium containing 0.1% FBS for 48 h: tetracycline was included in the culture medium to repress expression of HA-DP-1. After serum deprivation,¯ow cytometry showed that greater than 90% of the cells in the D1-38 culture contained a 2C DNA content, and were therefore arrested in G1 (Figure 7a ). In the presence of 0.1% FBS, expression of HA-DP-1 at any level was unable to induce S phase entry. When serum was added in the presence of 1 mg/ml tetracyline, about 80% of the cell population entered the S phase by 16 h (Figure 7a ). However, when lower concentrations of tetracycline were included in the medium containing 5% FBS, a biphasic response was observed. At 100 ng/ ml tetracycline, expression of HA-DP-1 potentiated S phase entry and DNA synthesis (Figure 7a,b) . At lower concentrations of tetracycline, cells were inhibited from entering the S phase and DNA synthesis was inhibited in a manner proportional to the level of expression of HA-DP-1 (Figure 7a,b) .
Thus, in 5% FBS, as the concentration of tetracycline was decreased below 100 ng/ml culture medium, the level of expression of HA-DP-1 increased, and DNA synthesis decreased proportionately. Cells incubated in 0.1% FBS did not synthesize DNA above background levels in any concentration of tetracycline (Figure 7b) . Hence, both¯ow cytometry and analysis of [ 3 H]thymidine incorporation into DNA showed that high levels of HA-DP-1 suppressed the ability of 5% FBS to induce D1-38 cells to enter the S phase. In addition, cell growth curves showed that expression of HA-DP-1 inhibited D1-38 cell growth in a manner that was inversely proportional to the concentration of tetracycline in the growth medium (data not shown).
Inhibition of cell cycle progression by HA-DP-1 is related to the accumulation of ubiquitinated proteins, including c-jun and p21
In D1-38 cells, expression of HA-DP-1 led to increased E2F DNA binding activity and increased levels of dhfr gene expression during traversal of G1, suggesting HA-DP-1 potentiated E2F-dependent gene expression. Yet expression of HA-DP-1 clearly inhibited S phase entry. To ascertain the reason for this discrepancy, we a b Figure 7 Elevated expression of HA-DP-1 inhibits cell cycle progression. (a) D1-38 cells were arrested in G1 in medium containing 0.1% FBS and 1 mg/ml tetracycline. After 48 h, medium containing either 0.1 or 5% FBS, with the indicated concentration of tetracycline, was added. After 16 h, the distribution of cells within the cell cycle was determined by¯ow cytometry. Each individual histogram displays the relative cell number (vertical axis) versus DNA content as measured by PĪ uorescence (horizontal axis). Cells with a diploid (or G1) DNA content are denoted as 2C, while those that have completed the S phase are denoted as 4C. (b) D1-38 cells were arrested in early G1 as before and replicate cultures were then incubated in fresh medium containing 0.1% FBS (*) or 5% FBS (*) with the indicated concentration of tetracycline for 17 h. DNA synthesis then was measured by determining the amount of [ examined the eect of elevated expression of HA-DP-1 (and HA-E2F-1) on the levels of other ubiquitinated cellular proteins. Total cell lysates were prepared from unsynchronized D1-38 and E1-12 cells at 24 h intervals after removal of tetracycline, and Western blots were probed with an anity-puri®ed polyclonal antiubiquitin antibody preparation. After 24 h, expression of HA-DP-1 caused the accumulation of numerous ubiquitinated proteins, which appeared as a smear throughout the length of the gel in Western blots ( Figure 8 , lanes 2 ± 6). In marked contrast, expression of HA-E2F-1 reduced rather than increased the amount of ubiquitinated proteins (Figure 8 , lanes 7 ± 11). Similar results were obtained when monoclonal anti-ubiquitin antibody 4F3 was used to detect ubiquitinated proteins (data not shown).
We then asked if expression of HA-DP-1 in¯uenced the levels of two proteins involved in growth control that are known to be ubiquitinated, c-jun (Treier et al., 1994) and the CKI p21 (Maki et al., 1996; Chang et al., 1998) . These two proteins were selected for study because p21 (also known as CIP1, WAF1, and Sdi1) is known to in¯uence E2F activity through cdks (ElDeiry et al., 1993; Harper et al., 1993; Xiong et al., 1993) , while c-jun is not known to be involved in regulating E2F activity. In unsynchronized cells, both c-jun and p21 accumulated to high levels in D1-38 cells when HA-DP-1 was expressed (Figure 9a ). The levels of c-jun and p21 were inversely proportional to the concentration of tetracycline in the culture medium, and directly proportional to the level of expression of HA-DP-1 (Figure 9a ). While c-jun and p21 accumulated in D1-38 cultures incubated in either 0.1 and 5% FBS, levels of p21 were signi®cantly higher in cells incubated in 5% FBS (Figure 9a ). In serum response experiments, expression of HA-DP-1 induced the accumulation of both c-jun and p21 during transition of G1 (Figure 9b, lanes 1 ± 5) . Note the accumulation of a series of high molecular weight bands in the p21 Figure 8 Expression of HA-DP-1 induces the accumulation of ubiquitinated cellular proteins. A Western blot of total cell lysates from CHOC 400 cells (lane 1), D1-38 cells, or E1-12 cells was probed with an anity-puri®ed polyclonal antibody against ubiquitin. Replicate cultures of D1-38 and E1-12 cells were initially cultured in medium containing 1 mg/ml tetracycline (time 0), and then were incubated in medium without tetracycline for the indicated number of days. Molecular weight markers are indicated at right Figure 9 Expression of HA-DP-1 induces the accumulation of c-jun and p21. (a) D1-38 cells were arrested in early G1 by incubation in medium containing 0.1% FBS with 1.0 mg/ml tetracycline for 48 h. Replicate cultures were then incubated in fresh medium containing 0.1% FBS or 5% FBS with the indicated concentration of tetracycline (ng/ml) for 20 h. Cell extracts were prepared and probed for the expression of DP-1 with WTH-10, c-jun with mouse monoclonal antibody KM-1, or p21 with rabbit polyclonal antibody C-19. (b) D1-38 cells were arrested in early G1 by incubation in medium containing 0.1% FBS and tetracycline. After 48 h, medium containing 5% FBS, with or without tetracycline, was added. At 4 h intervals whole cell lysates were prepared and examined for c-jun expression or p21 expression by Western blotting as above Western blot. As expected, addition of medium with 5% FBS to serum-starved D1-38 cells that were not expressing HA-DP-1 reduced p21 levels as cells transited G1 and entered S phase (Figure 9b , lanes 6 ± 10). As in transiently transfected cells, HA-DP-1 did not accumulate in the cell nucleus, whereas HA-E2F-1 was predominantly nuclear (Figure 10 ). Phase microscopy showed that cells expressing HA-DP-1 display lacy cytoplasmic inclusions (Figure 10 ). When D1-38 cells expressing HA-DP-1 were stained with antibodies to both DP-1 and ubiquitin, cytoplasmic HA-DP-1 displayed a signal that colocalized with ubiquitin in the cytoplasmic inclusion bodies (data not shown). Immun¯uorescence signals for ubiquitin were rarely observed in cells not expressing HA-DP-1.
Discussion
E2F plays an important role in the regulation of genes required for DNA replication and cell cycle progression. E2F function has proven exceedingly complex: the E2F and DP protein families consist of multiple members which form an array of DNA binding complexes with transactivation activity (Slansky and Farnham, 1996) . E2F/DP heterodimers show differences in their ability to associate with pRB, p130, or p107, bind cyclins and cdks, and drive cell cycle progression (reviewed by Sidle et al., 1996; Adams and Kaelin, 1996; Beijersbergen and Bernards, 1996; Sanchez and Dynlacht, 1996; Slansky and Farnham, 1996; Weinberg, 1995) . Other work shows that E2F subunits dier in their ability to alter the intracellular distribution of DP-1 and DP-2 (Magae et al., 1996; Lindeman et al., 1997) and that nuclear localization in¯uences the activity of E2F during cell cycle progression (Lindeman et al., 1997; Muller et al., 1997; Verona et al., 1997) . In addition, association of pRB family members or viral oncoproteins with E2F heterodimers stabilizes E2F polypeptides by altering their metabolism by the ubiquitin-proteasome pathway (Campanero and Flemington, 1997; Hateboer et al., 1996 , Hofmann et al., 1996 . Together these studies indicate that heterodimerization of E2F and DP proteins in¯uences the subcellular distribution of E2F, and that subcellular tracking of the proteins is regulated during the cell cycle.
Elevated expression of E2F subunits has been used in a number of studies on the relationship between E2F-dependent gene expression and cell cycle progression. Provided they are able to gain access to the nucleus, E2Fs 1 ± 5 are able to bypass a number of regulatory steps in G1 and induce S phase entry (reviewed by Adams and Kaelin, 1996; see also Muller et al., 1997; Lindeman et al., 1997) . Other than stabilizing DNA binding activity, and in¯uencing nuclear entry of E2F subunits, little in known about the precise function of DP-1 in E2F activity. In contrast to E2F subunits, elevated expression of DP-1 shows no or little ability to induce S phase. For example, Shan et al. have reported that expression of DP-1 fails to promote cell cycle entry even when fused to the VP-16 transcriptional transactivation domain (Shan et al., 1996) . Other studies report that transient expression of wild type DP-1 causes a modest increase in S phase cells . The work presented here suggests these disparate eects can be attributed to levels of DP-1 expression relative to the array of E2F subunits that are available for heterodimer complex formation.
Coexpression of truncated forms of E2F-1 with DP-1 shows that DP-1 that is able to associate stably with an E2F subunit in the cytoplasm enters the nucleus and is stable in the presence of cycloheximide for up to 12 h (Figure 3 ). Presumably it is this form of DP-1 that is capable of binding DNA and participating in the regulation of E2F-dependent gene expression. However, if no E2F subunit is available for complex
CHOC 400 Figure 10 Immunostaining of E1-12 and D1-38 cells. E1-12 and D1-38 cells were incubated in medium lacking tetracyline for 20 h prior to immunostaining for HA-E2F-1 with KH20 and HA-DP-1 with WTH10. The green FITC signal corresponds to HA-E2F-1 (top row) or HA-DP-1 (middle row), nuclear DNA was visualized by staining with propidium iodide (PI), and cells were visualized by phase contrast microscopy. CHOC 400 cells (bottom row) stained with KH20 were used as controls formation, newly translated DP-1 accumulates in the cytoplasm and is targeted for degradation by ubiquitindependent proteolysis. By eliminating free cytoplasmic DP-1, the ubiquitin-proteasome pathway may maintain the 1 : 1 stochiometry between E2F and DP-1 protein subunits. Several observations support the notion that levels of free E2F subunits govern intracellular level of E2F/ DP heterodimers and therefore E2F DNA binding activity. First, expression of DP-1 alone in growing D1-38 cells (Figure 5a ) or in transient transfection experiments (Wu et al., 1995) has little eect on total E2F DNA binding activity. We also have observed that expression of DP-1 in log phase cells has no eect on dhfr mRNA levels (data not shown). These results, and the fact that DP-1 expression is regulated by a TATA-less promoter similar to that of housekeeping genes (Gopalkrishnan et al., 1996) , suggest that under most conditions DP-1 is synthesized in amounts equal to or in excess of its E2F partners. During serum stimulation, however, induction of E2F protein expression during G1 may provide a suciently large pool of nascent E2F polypeptides that elevated expression of DP-1 is able to increase E2F DNA binding activity, perhaps through positive feedback on E2F gene expression (reviewed by Slansky and Farnham, 1996) .
During the serum response, DP-1 mRNA levels increase about threefold by mid-G1 (Schilling and Farnham, 1994) , a time when E2F complexes containing DP-1 begin to accumulate to high levels in CHOC 400 cells (Wells et al., 1997) . In contrast to cycling cells (Figure 5a ), expression of HA-DP-1 during serum stimulation in D1-38 cells resulted in a threefold increase in E2F DNA binding activity by mid-G1 ( Figure 5b ) and a corresponding increase in dhfr gene expression ( Figure 6 ). Thus, at maximal levels of expression during transition of G1, HA-DP-1 caused no more than a 3 ± 5-fold increase in E2F transcriptional activity. This modest increase in transcriptionally active free E2F may potentiate cell cycle progression, as previously reported and as shown here for D1-38 cells incubated in 100 ng/ml tetracycline, which express HA-DP-1 that is not highly ubiquitinated (Figure 4a, lane 3) and show increased levels of DNA synthesis after serum stimulation (Figure 7b) .
Despite activation of E2F-dependent genes like dhfr, we clearly observe a biphasic S phase response when DP-1 is conditionally expressed during transition of G1 after serum stimulation. At lower levels of expression, DP-1 increases the level of E2F DNA binding complexes, potentiates E2F-dependent gene expression, and accelerates S phase entry. With prolonged expression at high levels, DP-1 still potentiates E2F DNA binding activity, but fails to drive S phase entry. Inhibition of S phase entry occurred under the same conditions that resulted in increased expression of the dhfr gene, showing that the block to cell cycle progression was not due to a global failure to activate E2F-dependent gene expression. Under these conditions polyubiquitinated DP-1 accumulates in the cell cytoplasm, saturating the proteasome system, thereby leading to the accumulation of other proteins targeted for degradation during G1. These results support transfection experiments which show DP-1 that does not associate with an E2F subunit is targeted for degradation by the ubiquitin-proteasome system (Figure 2 ). This notion also is supported by the observation that cytoplasmic DP-1 does not persist in the presence of cycloheximide (Figure 3 and data not shown).
The ubiquitin-proteasome pathway and cell cycle progression Ubiquitin-dependent proteolysis plays an important role in cell cycle progression, both during mitosis and in G1 (reviewed in Hochstrasser, 1995; King et al., 1996) . In yeast, the ubiquitin conjugating enzyme encoded by CDC34 is required for the degradation of p40 SIC1 , an inhibitor of G1 clb/cdc28 kinase complexes required for S phase entry (Schowb et al., 1994) . Because they are unable to degrade p40 SIC1 , yeast cells lacking CDC34 arrest at the G1/S phase boundary of the cell cycle. In animal cells, the CKIs p21 CIP1/WAF1 (Maki et al., 1996; Chang et al., 1998) and p27 (Pagano et al., 1995) are also degraded by a ubiquitindependent pathway. Of the many ubiquitinated proteins that accumulate in the presence of polyubiquitinated HA-DP-1 (see Figure 8 ), p21 is a strong candidate as one factor that would aect cell cycle progression, for this protein inhibits the activity of cdk/ cyclin complexes required for S phase entry (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993) . Previously we have shown that p21 is polyubiquitinated and accumulates in the presence of proteasome inhibitors in several cell types (Chang et al., 1998) . Upon induction of cell cycle progression by FBS in D1-38 cells incubated with tetracycline, p21 levels decline as cells approach S phase (Figure 9b ), as they do in parental CHOC 400 cells (data not shown). In D1-38 cells incubated without tetracycline, p21 and immunoreactive forms of p21 that comigrate with polyubiquitinated p21 accumulate ( Figure 9b ) and cells fail to enter the S phase (Figure 7a ).
Recently it has been shown that expression of E2F-1 is able to over-ride cell cycle arrest due to expression of CKIs, including p21 (DeGregori et al., 1995; Lukas et al., 1996) . In E1-12 cells, expression of HA-E2F-1 markedly reduced the level of all ubiquitinated cellular proteins (Figure 8 ), suggesting that one mechanism by which E2F-1 may potentiate cell cycle progression is by stimulating degradation of CKIs and other proteins that inhibit cell cycle progression. Expression of E2F-1 therefore may bypass cell cycle arrest by CKIs not only by activating expression of downstream target genes, but by promoting degradation of CKIs. In transfection experiments this property of E2F-1 may alter the kinetics of assembly and activation of kinase complexes, leading to signi®cantly lower kinase activity in cell extracts, but permitting suciently high enough activity in vivo such that pRB and other important substrates are indeed phosphorylated (DeGregori et al., 1995) .
Cellular tracking of E2F and DP polypeptides
Nuclear entry is required for induction of S phase by E2F subunits (Muller et al., 1997) , and the capacity to enter the nucleus in the absence of a DP partner is one property that distinguishes E2Fs 1 ± 3 from E2Fs 4 and 5 (Magae et al., 1996; Lindeman et al., 1997) . Recent reports that the subcellular localization of E2F uctuates during the cell cycle (Verona et al., 1997; Lindeman et al., 1997) supports the notion that subcellular localization of E2F provides an additional level of control over E2F activity. To fully understand the role of each individual member of the E2F and DP protein families in gene expression and cell cycle control, it will be necessary to document which factors associate with one another in the cytoplasm under speci®c growth conditions, which of the resulting E2F/ DP complexes enter the nucleus and interact with speci®c subsets of cellular promoters, and how the distribution of each of these distinct complexes changes during the cell cycle.
Here only forms of E2F-1 that are able to form stable heterodimers with DP-1 were able to eect nuclear localization of DP-1 (Figure 3) . These same forms of E2F-1 also reduced the level of ubiquitination of DP-1 (Figure 2 ), indicating nuclear DP-1 which is in association with E2F-1 is not a substrate for ubiquitin modi®cation. In this regard, the eects of E2F-1 1-284 on DP-1 expression are illuminating. Based on previous work, the E2F-1 1-284/DP-1 heterodimer is likely to be unstable . Our work supports this observation, for E2F-1 1-284 is distributed in both the cytoplasm and nucleus, fails to promote complete nuclear localization of DP-1, and only partially protects DP-1 from polyubiquitination. In contrast to DP-1 expressed in the presence of E2F-1 1-119 or E2F-1 1-284, DP-1 that is coexpressed with E2F 1-374 persists in the presence of cycloheximide (Figure 3) . Moreover, ubiquitinated DP-1 is not recovered in association with E2F subunits in immunoprecipitation experiments (Figure 2 ).
Together these observations indicate that association with E2F subunits promotes nuclear entry of DP-1, and that DP-1 which does not associate with E2F-1 is degraded in the cytoplasm by the ubiquitin-proteasome pathway. Thus, as for E2F-1 and E2F-4, which are protected from ubiquitin-dependent degradation by association with pRB family proteins (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996) , complex formation with E2F may stabilize DP-1. Finally, DP-1 and DP-2 have been shown to cooperate with H-ras in cell transformation assays (Jooss et al., 1995) . In these assays the transforming activity of DP-1 and DP-2 proteins was not attributed to activation of E2F-dependent gene expression. Our results raise the possibility that DP proteins may in¯uence neoplastic transformation by perturbing the metabolism of other factors that are degraded by ubiquitin-dependent proteolysis, such as p53 (Maki et al., 1996) , which is known to functionally interact with DP-1 (Sorensen et al., 1996) .
Materials and methods
Construction of cell lines and cell synchrony
Tetracycline-responsive plasmid constructs pUHD15-1 and pUHD10-3 were a gift from H Bujard (Gossen and Bujard, 1992) . To generate pUHD-E2F1, the 1.33 kb BamHI fragment of pCMV-E2F1 (Helin et al., 1992) that contains the full length human E2F-1 coding sequence was subcloned into the BamHI site of pUHD10-3. pUHD-HA-DP1 was constructed by subcloning the 1.3 kb XmaI ± EcoRI fragment of pBSK-HA-DP1 that contains HAtagged DP-1 (Helin et al., 1993) into the BamHI site of pUHD10-3 by blunt-end ligation after both the vector and insert were ®lled-in with Klenow fragment. Responsiveness of the expression plasmids to tetracycline was con®rmed by cotransfection with pUHD15-1 in transient transfection experiments.
pUHD-E2F-1 or pUHD-HA-DP1 were cotransfected with pUHD-15-1-neo into CHOC 400 cells at a 5 : 1 ratio (250 and 50 ng, respectively per 9 cm culture dish) in the presence of 1 mg/ml tetracycline (Sigma, St Louis, MO). After 24 h, the culture was split 1 : 5, and incubated in DMEM containing 5% fetal bovine serum (FBS) and 400 mg/ml G418 (GIBCO-BRL, Gaithersburg, MD) for 7 ± 10 days. G418-resistant colonies were isolated in 96-well dishes, expanded in DMEM containing 5% FBS, G418, and tetracycline. Replicate cultures then were tested for expression of E2F-1 and HA-DP-1 in DMEM with and without tetracycline by Western blotting. Colonies that expressed E2F-1 and HA-DP-1 under the control of tetracycline were cloned by limiting dilution, and characterized by Western and Northern blotting, using extracts from CHOC cells that had been transiently transfected with pCMV expression plasmids as controls.
To synchronize cells in early G1, CHOC 400, E1-12, or D1-38 cells were trypsinized and plated in DMEM with 0.1% FBS and tetracycline for 48 h. Cells were stimulated to reenter the cell cycle by washing cultures four times with warm DMEM, and adding DMEM containing 5% FBS, with or without tetracycline as indicated. Cell synchrony was evaluated by¯ow cytometry as described by Telford et al. (1994) . To assay for DNA synthesis, radioactivity incorporated into DNA from cells incubated with 0.5 mCi [ 3 H]thymidine/ml for 3 h was measured in triplicate samples.
Transient transfection assays
Transient transfection experiments were performed with 2 ± 8 mg of supercoiled plasmid expression vector and sucient salmon sperm carrier DNA to provide a total of 24 mg DNA per 9 cm culture dish, using the calciumphosphate precipitation method as described previously (Helin et al., 1993; Magae et al., 1996) . In standard assays, DNA was added, 20 h later the cultures were washed three times with PBS, and were then incubated for an additional 24 h in fresh medium before harvest. pCMV-DP1, pCMV-HA-ubiquitin, and pCMV-His 6 -ubiquitin have been described previously (Treier et al., 1994; Wu et al., 1995) .
Northern blotting
Total RNA was isolated and analysed by Northern blotting as described previously (Shull et al., 1991) . RNA gels were loaded with 15 mg total RNA per lane and were stained with ethidium bromide after electrophoresis to ensure equal loading of RNA samples. Hybridization signals were quanti®ed with a Bio-Rad GS250 Molecular Imager.
Western blotting
Cells were lysed in 26SDS sample buer (120 mM TrisHCl [pH 6.8], 4% SDS, 100 mM DDT, 20% glycerol, 0.01% bromophenol blue), and a uniform amounts of each cell sample (20 ± 50 mg/gel lane) were resolved by electrophoresis in denaturing polyacrylamide gels. Protein concentrations were measured by diluting extracts prepared in SDS sample buer 1 : 500 in H 2 O and using absorbance at 320 nM to correct for absorbance at 280 and 260 nM (Warburg and Christian, 1942) . Prestained protein mixtures (Sigma) were used as molecular weight markers. After transfer to Immobilon-P membranes (Millipore, Bedford, MA), gels were stained with Coomassie brilliant blue R-250 to ensure uniform loading and transfer of protein samples. Blots were blocked in 5% nonfat dry milk in TBS-T (Tris-buered saline: 20 mM Tris-HCl, pH 7.5, 0.8% NaCl) with 0.01% Tween 20, probed with the indicated primary antibodies, and then with the appropriate horseradish peroxidase-coupled secondary antibody (Amersham). Signals were detected using the ECL system (Amersham, Piscatoway, NJ).
Preparation of whole cell extracts and gel shift assays
Whole cell extracts (WCEs) were analysed for E2F DNA binding activity using the overlapping E2F sites from the dihydrofolate reductase (dhfr) promoter as probe as described (Wells et al., 1996 (Wells et al., , 1997 . Brie¯y, for WCEs, cells were lysed in 100 mM HEPES, pH 7.4, 500 mM KCl, 5 mM MgCl 2 0.5 mM EDTA, 35% glycerol, 5 mM NaF, 2 mg/ml phenylmethylsulfonyl¯ouride, 0.1 mg/ml aprotinin, 0.1 mg/ml leupeptin, and 1 mM DTT, incubated on ice for 30 min, and spun at 300 000 g for 15 min at 48C. For antibody supershifts, 20 ml reactions containing 3.5 mg of WCE was incubated with non-speci®c DNA and 1 ± 4 ul of the indicated antibody for 10 min at room temperature, labeled probe was then added, and the reaction was incubated an additional 20 min. Protein-DNA complexes were resolved on neutral 4% polyacrylamide gels and visualized by autoradiography. The components of individual complexes were identi®ed by antibody supershift assays as described previously (Wells et al., 1997) .
Immunoprecipitations
For immunoprecipitation of DP-1 from total cell lysates, 24 h after transfection CHOC 400 cells were washed three times with PBS and lysed in PBS containing 2% SDS. Cell lysates were sonicated for 10 s and heated to 958C for 10 min. After centrifugation for 10 min at 14 000 r.p.m. in a microfuge, 100 ml of supernatant was diluted with 4 ml PBS, and 0.5 ml of hybridoma WTH10 or KH20 culture supernatant was added. After incubation for 1 h at 48C, 100 ml of anti-mouse IgG agarose beads (Sigma) were added to each sample, and the lysates were incubated for 1 h at 48C. The beads then were washed six times with TBS-T, suspended in 26SDS sample buer containing 100 mM DTT, heated for 10 min at 958C, and resolved on 8% denaturing polyacrylamide gels. After transfer to Immobilon-P membranes (Millipore), signals were detected by ECL as described above.
For immunoprecipitations from WCEs used in gel shift experiments, WCEs were diluted with ®ve volumes PBS, 0.5 ml of hybridoma supernatant was added, and the samples were processed as above. Insoluble components from either total cell lysates or WCEs were solubilized by suspending residual cell pellets in PBS containing 2% SDS, repeated sonication, and heating at 958C for 10 min.
Immuno¯uorescence microscopy
Cells on cover slips were ®xed with 2% paraformaldehyde in PBS, permeabilized with PBS containing 0.1% Triton X-100, and stained with primary antibodies and the appropriate¯uorescent dye-conjugated secondary antibodies as described previously (Magae et al., 1996) . After immunostaining, cellular DNA was stained with either propidium iodide (PI) at 1 mg/ml or 4, 6-diamidino-2-phenylindole (DAPI) at 10 ng/ml.
Antibodies
Monoclonal antibodies KH20, CP36, 12CA5, and WTH10 have been described previously (Field et al., 1988; Helin et al., 1993; Wu et al., 1995) . Rabbit polyclonal antibodies against c-jun (N), DP-1(K-12), p21(C-19) and mouse monoclonal antibody against c-jun (KM-1) were from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). Anity-puri®ed polyclonal chicken anti-ubiquitin antibody was a gift from L Prakash (UTMB, Galveston, TX, USA). Monoclonal antibody 4F3 against ubiquitin was a gift from L Guarino.
